Universal-Beteiligungs- und Servicegesellschaft’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.47M Buy
46,713
+6,688
+17% +$671K 0.01% 904
2026
Q1
$3.7M Buy
40,025
+15,899
+66% +$1.5M 0.01% 1005
2025
Q4
$1.91M Buy
24,126
+17,552
+267% +$1.26M ﹤0.01% 1273
2025
Q3
$482K Buy
6,574
+1,848
+39% +$117K ﹤0.01% 1762
2025
Q2
$241K Buy
+4,726
New +$210K ﹤0.01% 1885

Other funds holding MIRM

Universal-Beteiligungs- und Servicegesellschaft's MIRM Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Mirum Pharmaceuticals (MIRM) stake by 17% in Q2 2026, buying an estimated $671K and bringing the position to 46,713 shares worth $5.47M. The position accounts for 0.01% of the portfolio, ranked #904.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 46,713 shares of Mirum Pharmaceuticals worth $5.47M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 6,688 Mirum Pharmaceuticals shares in Q2 2026, an estimated $671K.
  • Mirum Pharmaceuticals made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #904 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.